Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Context Therapeutics Inc.
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 9, 2026
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
May 31, 2026
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 30, 2026
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
May 28, 2026
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
May 23, 2026
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
May 22, 2026
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
May 20, 2026
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026